Literature DB >> 27534407

[Prognosis in young women with early stage breast cancer].

René Baumann1, Jürgen Dunst2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27534407     DOI： 10.1007/s00066-016-1033-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  9 in total

1.  Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer.

Authors:  Usama Mahmood; Christopher Morris; Geoffrey Neuner; Matthew Koshy; Susan Kesmodel; Robert Buras; Saranya Chumsri; Ting Bao; Katherine Tkaczuk; Steven Feigenberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-01-31       Impact factor: 7.038

2.  A Rosier Picture for Young Women With Breast Cancer.

Authors:  Ellen Warner
Journal:  J Clin Oncol       Date:  2016-04-04       Impact factor: 44.544

3.  Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831.

Authors:  Edith A Perez; Edward H Romond; Vera J Suman; Jong-Hyeon Jeong; George Sledge; Charles E Geyer; Silvana Martino; Priya Rastogi; Julie Gralow; Sandra M Swain; Eric P Winer; Gerardo Colon-Otero; Nancy E Davidson; Eleftherios Mamounas; Jo Anne Zujewski; Norman Wolmark
Journal:  J Clin Oncol       Date:  2014-10-20       Impact factor: 44.544

4.  Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.

Authors:  A C Voogd; M Nielsen; J L Peterse; M Blichert-Toft; H Bartelink; M Overgaard; G van Tienhoven; K W Andersen; R J Sylvester; J A van Dongen
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

5.  Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.

Authors:  G H de Bock; J A van der Hage; H Putter; J Bonnema; H Bartelink; C J van de Velde
Journal:  Eur J Cancer       Date:  2005-11-28       Impact factor: 9.162

6.  Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival.

Authors:  P H Elkhuizen; M J van de Vijver; J Hermans; H M Zonderland; C J van de Velde; J W Leer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

7.  Contemporary Locoregional Recurrence Rates in Young Patients With Early-Stage Breast Cancer.

Authors:  Kim C Aalders; Emily L Postma; Luc J Strobbe; Margriet van der Heiden-van der Loo; Gabe S Sonke; Liesbeth J Boersma; Paul J van Diest; Sabine Siesling; Thijs van Dalen
Journal:  J Clin Oncol       Date:  2016-03-14       Impact factor: 44.544

8.  Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.

Authors:  A J Nixon; D Neuberg; D F Hayes; R Gelman; J L Connolly; S Schnitt; A Abner; A Recht; F Vicini; J R Harris
Journal:  J Clin Oncol       Date:  1994-05       Impact factor: 44.544

9.  Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.

Authors:  Jennifer L Gnerlich; Anjali D Deshpande; Donna B Jeffe; Allison Sweet; Nick White; Julie A Margenthaler
Journal:  J Am Coll Surg       Date:  2009-01-21       Impact factor: 6.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.